Page last updated: 2024-11-07

dextroamphetamine and Precancerous Conditions

dextroamphetamine has been researched along with Precancerous Conditions in 1 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Miglio, MR1
Muroni, MR1
Simile, MM1
Calvisi, DF1
Tolu, P1
Deiana, L1
Carru, A1
Bonelli, G1
Feo, F1
Pascale, RM1

Other Studies

1 other study available for dextroamphetamine and Precancerous Conditions

ArticleYear
Implication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions.
    Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:4

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Coloring Agents; Dextroamphetamine; Diethylnitrosami

2000